Should You Worry?
The CDC reports a significant rise in Candida auris cases across the United States, with thousands of infections recorded annually. Experts are concerned about the pathogen's increasing resistance to standard antifungal medications and its ability to persist in healthcare environments.
Why it matters
The emergence of drug-resistant fungal infections poses a serious threat to public health, particularly for vulnerable patients in acute care settings.
The Centers for Disease Control and Prevention (CDC) reports that more than 3,000 cases of Candida auris have been reported in 23 states so far this year.
Texas has the most cases with 706 as of July 18. Michigan is second with 503 cases, and Illinois is third with 366 cases.
Another CDC report , issued in early July, noted annual increases in Candida auris cases between 2022 and 2024. The report stated that there were 2,882 cases nationwide in 2022, followed by 4,428 cases in 2023 and 6,197 cases in 2024.
The report noted that 88% of clinic cases of fungal infection were among people ages 45 and older. The majority of cases were in males, and most occurred in acute care facilities.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in